(31 days)
Not Found
No
The device description and performance studies focus on the chemical composition, stability, and traceability of the calibrator solution. There is no mention of AI or ML in the intended use, device description, or performance data. The calculation of intermediate levels is described as being performed by the Dimension Vista™ System, which is a separate instrument and not the calibrator itself.
No.
This device is an in vitro diagnostic product intended for the calibration of various methods on a laboratory system, not for directly treating a patient's disease or condition.
Yes
The product is explicitly stated as an "in vitro diagnostic product for the calibration of acetaminophen (ACTM), carbamazepine (CRBM), digitoxin (DGTX), gentamicin (GENT), lidocaine (LIDO), Nacetylprocainamide (NAPA), procainamide (PROC), tobramycin (TOBR), valproic acid (VALP), and vancomycin (VANC) methods on the Dimension Vista TM System." This indicates its role in ensuring the accuracy of diagnostic tests.
No
The device is a physical, liquid-based in vitro diagnostic product used for calibrating an instrument. It is not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use/Indications for Use: The very first section explicitly states, "The DRUG 2 CAL is an in vitro diagnostic product for the calibration of acetaminophen... methods on the Dimension Vista TM System." This directly identifies it as an IVD.
- Device Description: It describes a product used to calibrate methods for detecting specific substances (drugs) in a sample (implied to be biological, as it's used on a system that would analyze patient samples). Calibration is a crucial step in ensuring the accuracy of in vitro diagnostic tests.
- Traceability: The mention of traceability to United States Pharmacopeia Reference Materials and Alltech-Applied Sciences Reference Standards further supports its role in ensuring the accuracy and reliability of diagnostic measurements.
- Predicate Device: The mention of a predicate device (K033809; Dimension® Drug Calibrator II) which is also a calibrator for drug methods, indicates that this type of product is regulated as an IVD.
Therefore, based on the provided information, the DRUG 2 CAL is clearly an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The DRUG 2 CAL is an in vitro diagnostic product for the calibration of acetaminophen (ACTM), carbamazepine (CRBM), digitoxin (DGTX), gentamicin (GENT), lidocaine (LIDO), Nacetylprocainamide (NAPA), procainamide (PROC), tobramycin (TOBR), valproic acid (VALP), and vancomycin (VANC) methods on the Dimension Vista TM System.
Product codes (comma separated list FDA assigned to the subject device)
DKB
Device Description
DRUG 2 CAL is a multi-analyte, liquid, bovine serum based product containing acetaminophen, carbamazepine, digitoxin, gentamicin, lidocaine, N-acetylprocainamide, procainamide, tobramycin, valproic acid, and vancomycin.
The kit consists of six vials, three vials of Calibrator A, and three vials of Calibrator B which are ready for use (no preparation is required). The volume per vial is 2.5 mL. Intermediate levels are automatically prepared and corresponding values calculated by the Dimension Vista™ System.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
1. Stability:
Target shelf life for the Dimension Vista™ System Drug 2 Calibrator is 12 months. Calibrator shelf life is determined by comparing results of the product stored at 4℃ with control stored at -20°C. The method is calibrated from this stored material. The 4℃ material values are recovered versus the calibration. Recovery versus time is monitored and percent change over time is determined. Percent change should be less than or equal to 5%. Shelf-life stability (expiration) dating assignment at commercialization reflects the real-time data on file at Dade Behring, Inc. A vial punctured by the instrument and stored on board is stable for 24 hours. An open vial not on instrument, but recapped and stored in a refrigerator is stable for 31 days. For testing, vials are opened /punctured on day zero. A quantity sufficient for multiple calibrations is removed and the vials are recapped and stored at 2 - 8 °C. Opened/punctured vials are tested on days 0, 1, 2, 8, and 32 versus freshly opened vials.
2. Traceability:
The assigned values of the DRUG 2 CAL are traceable to United States Pharmacopeia Reference Materials except for NAPA, which is traceable to Alltech-Applied Sciences Reference Standards.
3. Bottle Value Assignment:
Acetaminophen, Carbamazepine, Digitoxin, Gentamicin, Lidocaine, N-acetylprocainamide, Procainamide, Tobramycin, Valproic Acid and Vancomycin Reference Material is weighed into bovine serum albumin at six levels and stored frozen. The verification of the Master Pool values are compared against previously approved Master Pool values. The approved Master Pool values were assigned with an instrument calibrated with the corresponding standard reference material. The stock solution is made by adding Acetaminophen, Carbamazepine, Digitoxin, Gentamicin, Lidocaine, N-acetylprocainamide, Procainamide, Tobramycin, Valproic Acid and Vancomycin Reference Materials gravimetrically to stock solution at target concentrations and verified on an instrument calibrated with a previously approved Master Pool. The commercial lot is made by adding calculated quantities of stock solution to bovine serum albumin in appropriate concentrations for each of the calibrator levels. The concentration of each level is verified by using an instrument calibrated with Master Pools.
The final bottle values for each level of the commercial lot is assigned and verified using multiple instruments by testing N = 20 replicates per level. A previously released commercial lot is used as a control.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.3200 Clinical toxicology calibrator.
(a)
Identification. A clinical toxicology calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. A clinical toxicology calibrator can be a mixture of drugs or a specific material for a particular drug (e.g., ethanol, lidocaine, etc.). (See also § 862.2 in this part.)(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
Kouzi21
AUG 25 2006
510(k) Summary for the Dimension Vista™ System Drug 2 Calibrator (DRUG 2 CAL - KC420)
A. 510(k) Number:
| B. Analytes: | Acetaminophen (ACTM), carbamazepine (CRBM), digitoxin
(DGTX), gentamicin (GENT), lidocaine (LIDO), N-
acetylprocainamide (NAPA), procainamide (PROC), tobramycin
(TOBR), valproic acid (VALP), and vancomycin (VANC). |
|------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| C. Type of Test: | Calibrator Material |
| D. Applicant: | Dade Behring Inc., P.O. Box 6101, Newark, DE 19714-6101
Victor M. Carrio, Regulatory Affairs and Compliance Manager
Office: (302) 631-0376 Fax: (302) 631-6299 |
E. Proprietary and Established Names:
Dimension Vista™ System Drug 2 Calibrator (DRUG 2 CAL - KC420)
F. Regulatory Information:
-
- Regulation section: 21 CFR § 862.3200 -- Clinical Toxicology Calibrator
-
- Classification: Class II
-
- Product Code: DKB Calibrator, Drug Mixture
-
- Panel: Toxicology
- G. Intended Use: The DRUG 2 CAL is an in vitro diagnostic product for the calibration of acetaminophen (ACTM), carbamazepine (CRBM), digitoxin (DGTX), gentamicin (GENT), lidocaine (LIDO), Nacetylprocainamide (NAPA), procainamide (PROC), tobramycin (TOBR), valproic acid (VALP), and vancomycin (VANC) methods on the Dimension Vista TM System.
H. Device Description:
DRUG 2 CAL is a multi-analyte, liquid, bovine serum based product containing acetaminophen, carbamazepine, digitoxin, gentamicin, lidocaine, N-acetylprocainamide, procainamide, tobramycin, valproic acid, and vancomycin.
1
The kit consists of six vials, three vials of Calibrator A, and three vials of Calibrator B which are ready for use (no preparation is required). The volume per vial is 2.5 mL. Intermediate levels are automatically prepared and corresponding values calculated by the Dimension Vista™ System.
I. Substantial Equivalence Information:
| New Device | Predicate Device | |
|---|---|---|
| Item | Dimension Vista™ System | |
| Drug 2 Calibrator | Dimension® Drug Calibrator II | |
| K033809 | ||
| Intended | ||
| Use | The DRUG 2 CAL is an in vitro diagnostic | |
| product for the calibration of | ||
| acetaminophen (ACTM), carbamazepine | ||
| (CRBM), digitoxin (DGTX), gentamicin | ||
| (GENT), lidocaine (LIDO), N- | ||
| acetylprocainamide (NAPA), procainamide | ||
| (PROC), tobramycin (TOBR), valproic acid | ||
| (VALP), and vancomycin (VANC) methods | ||
| on the Dimension Vista™ System. | Drug Calibrator II is an in vitro diagnostic | |
| product intended for the calibration of the | ||
| following methods packaged in Flex® | ||
| reagent cartridges: acetaminophen (ACTM), | ||
| carbamazepine (CRBM), digitoxin | ||
| (DGTX), gentamicin (GENT), lidocaine | ||
| (LIDO), N-acetylprocainamide (NAPA), | ||
| procainamide (PROC), tobramycin | ||
| (TOBR), valproic acid (VALP), | ||
| vancomycin (VANC). | ||
| Analytes | Acetaminophen (ACTM), carbamazepine | |
| (CRBM), digitoxin (DGTX), gentamicin | ||
| (GENT), lidocaine (LIDO), N- | ||
| acetylprocainamide (NAPA), procainamide | ||
| (PROC), tobramycin (TOBR), valproic acid | ||
| (VALP), and vancomycin (VANC). | Acetaminophen (ACTM), carbamazepine | |
| (CRBM), digitoxin (DGTX), gentamicin | ||
| (GENT), lidocaine (LIDO), N- | ||
| acetylprocainamide (NAPA), procainamide | ||
| (PROC), tobramycin (TOBR), valproic acid | ||
| (VALP), and vancomycin (VANC). | ||
| Form | Liquid. | Liquid. |
| Traceability | USP¹ for all analytes except NAPA. | |
| NAPA - Alltech-Applied Sciences | ||
| Reference Standards. | USP¹ for all analytes except NAPA. | |
| NAPA - Alltech-Applied Sciences | ||
| Reference Standards. | ||
| Matrix | Bovine serum based. | Bovine serum based. |
| Number of | ||
| Levels | Two levels². | Five levels. |
' United States Pharmacopeia.
2 Intermediate levels are automatically prepared and corresponding values calculated by the Dimension Vista™ System.
J. Standard/Guidance Document Referenced:
-
- Guidance: Guidance for Industry - Abbreviated 510(k) Submissions for In Vitro Diagnostic Calibrators; Final, 02/22/1999 Guidance for Industry and FDA Staff - Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use, 11/30/2004
-
- Standards: CEN 13640 Stability testing of In-Vitro Diagnostic Devices ISO 14971:2000 Medical devices -Application of risk management to medical devices
2
K. Performance Characteristics:
-
Target shelf life for the Dimension Vista™ System Drug 2 1. Stability: Calibrator is 12 months. Calibrator shelf life is determined by comparing results of the product stored at 4℃ with control stored at -20°C. The method is calibrated from this stored material. The 4℃ material values are recovered versus the calibration. Recovery versus time is monitored and percent change over time is determined. Percent change should be less than or equal to 5%. Shelf-life stability (expiration) dating assignment at commercialization reflects the real-time data on file at Dade Behring, Inc. A vial punctured by the instrument and stored on board is stable for 24 hours. An open vial not on instrument, but recapped and stored in a refrigerator is stable for 31 days. For testing, vials are opened /punctured on day zero. A quantity
sufficient for multiple calibrations is removed and the vials are recapped and stored at 2 - 8 °C. Opened/punctured vials are tested on days 0, 1, 2, 8, and 32 versus freshly opened vials. -
- Traceability: The assigned values of the DRUG 2 CAL are traceable to United States Pharmacopeia Reference Materials except for NAPA, which is traceable to Alltech-Applied Sciences Reference Standards.
-
- Bottle Value Assignment:
Acetaminophen, Carbamazepine, Digitoxin, Gentamicin, Lidocaine, N-acetylprocainamide, Procainamide, Tobramycin, Valproic Acid and Vancomycin Reference Material is weighed into bovine serum albumin at six levels and stored frozen. The verification of the Master Pool values are compared against previously approved Master Pool values. The approved Master Pool values were assigned with an instrument calibrated with the corresponding standard reference material. The stock solution is made by adding Acetaminophen. Carbamazepine, Digitoxin, Gentamicin, Lidocaine, Nacetylprocainamide, Procainamide, Tobramycin, Valproic Acid and Vancomycin Reference Materials gravimetrically to stock solution at target concentrations and verified on an instrument calibrated with a previously approved Master Pool. The commercial lot is made by adding calculated quantities of stock solution to bovine serum albumin in appropriate concentrations for each of the calibrator levels. The concentration
3
of each level is verified by using an instrument calibrated with Master Pools.
The final bottle values for each level of the commercial lot is assigned and verified using multiple instruments by testing N = 20 replicates per level. A previously released commercial lot is used as a control.
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the caduceus symbol. The logo is black and white.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
AUG 2 5 2006
Mr. Victor M. Carrio RA/OS Compliance Manager Dade Behring, Inc. P.O. Box 6101 Mailstop 514 Newark, DE, 19714-6101
K062121 Re:
Trade/Device Name: Dimension Vista™ Drug 2 Calibrator (KC420) Regulation Number: 21 CFR 862.3200 Regulation Name: Clinical Toxicology Calibrator Regulatory Class: Class II Product Code: DKB Dated: July 24, 2006 Received: July 25, 2006
Dear Mr. Carrio:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
5
Page 2 -
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market,
If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Alberto Guti
Alberto Guticarez, Ph.D. Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number (if known): K062121
Device Name:
Dimension Vista™ Drug 2 Calibrator (KC420)
Indications For Use:
The DRUG 2 CAL is an in vitro diagnostic product for the calibration of acetaminophen (ACTM), carbamazepine (CRBM), digitoxin (DGTX), gentamicin (GENT), lidocaine (LIDO), N-acetylprocainamide (NAPA), procainamide (PROC), tobramycin (TOBR), valproic acid (VALP), and vancomycin (VANC) methods on the Dimension Vista™ System.
Prescription Use
AND/OR
Over-The-Counter Use
(Part 21 CFR 801 Subpart D)
(21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Division Sign-Off
Office of In Vitro Diagnostic Device Evaluation and Safety
Page 1 of 1